Familial combined hyperlipidemia is associated with upstream transcription factor 1 (USF1)

Nature Genetics

Volumn 36, Issue 4, 2004, Pages 371-376

  Pajukanta, Päivi ^a   Lilja, Heidi E ^b,c   Sinsheimer, Janet S ^a,d   Cantor, Rita M ^a,d   Lusis, Aldons J ^a,d   Gentile, Massimiliano ^b,c   Duan, Xiaoqun Joyce ^a   Soro Paavonen, Aino ^e   Naukkarinen, Jussi ^b,c   Saarela, Janna ^b,c   Laakso, Markku ^f   Ehnholm, Christian ^b,c   Taskinen, Marja Riitta ^e   Peltonen, Leena ^a,b,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^c UNIVERSITY OF HELSINKI   (Finland)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^f UNIVERSITY OF EASTERN FINLAND   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; GENE PRODUCT; THIOREDOXIN INTERACTING PROTEIN; TRANSCRIPTION FACTOR; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; UPSTREAM STIMULATORY FACTOR 1;

ARTICLE; CHOLESTEROL BLOOD LEVEL; CHROMOSOME 1Q; FAMILIAL HYPERLIPEMIA; FEMALE; FINLAND; GENE CONTROL; GENE LOCUS; GENETIC ASSOCIATION; GENETIC LINKAGE; GENOTYPE; GLUCOSE METABOLISM; HAPLOTYPE; HUMAN; ISCHEMIC HEART DISEASE; LIPID METABOLISM; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PHENOTYPE; PRIORITY JOURNAL; TRIACYLGLYCEROL BLOOD LEVEL;

ANIMALS; CARRIER PROTEINS; CHROMOSOMES, HUMAN, PAIR 1; DNA-BINDING PROTEINS; GENES, REPORTER; HUMANS; HYPERLIPIDEMIA, FAMILIAL COMBINED; POLYMORPHISM, SINGLE NUCLEOTIDE; THIOREDOXIN; TRANSCRIPTION FACTORS; UPSTREAM STIMULATORY FACTORS;

EID: 12144287541     PISSN: 10614036     EISSN: None     Source Type: Journal    
DOI: 10.1038/ng1320     Document Type: Article

References (30)

1. Goldstein, J.L., Schrott, H.G., Hazzard, W.R., Bierman, E.L. & Motulsky, A.G. Hyperlipidemia in coronary heart disease II. Genetic analysis of lipid levels in 176 families and delineation of a new inherited disorder, combined hyperlipidemia. J. Clin. Invest. 52, 1544-1568 (1973).
2. Nikkilä, E.A. & Aro, A. Family study of serum lipids and lipoproteins in coronary heart disease. Lancet 1, 954-959 (1973).
3. Pajukanta, P. et al. Linkage of familial combined hyperlipidemia to chromosome 1q21q23. Nat. Genet. 18, 369-373 (1998).
4. Coon, H. et al. Replication of linkage of familial combined hyperlipidemia to chromosome 1q with additional heterogeneous effect of apolipoprotein A-I/C-III/A-IV locus: the NHLBI family heart study. Arterioscler. Thromb. Vasc. Biol. 20, 2275-2280 (2000).
5. Pei, W. et al. Support for linkage of familial combined hyperlipidemia to chromosome 1q21-q23 in Chinese and German families. Clin. Genet. 57, 29-34 (2000).
6. Allayee, A. et al. Locus for elevated apolipoprotein B levels on Chromosome 1p31 in families with familial combined hyperlipidemia. Circ. Res. 90, 926-931 (2002).
7. Elbein, S.C., Hoffman, M.D., Teng, K., Leppert, M.F. & Hasstedt, S.J. A genome-wide search for type 2 diabetes susceptibility genes in Utah Caucasians. Diabetes 48, 1175-1182 (1999).
8. Hanson, R.L. et al. An autosomal genomic scan for loci linked to type II diabetes mellitus and body-mass index in Pima Indians. Am. J. Hum. Genet. 634, 1130-1138 (1998).
9. Vionnet, N. et al. Genomewide search for type 2 diabetes-susceptibility genes in French whites: evidence for a novel susceptibility locus for early-onset diabetes on chromosome 3q-qter and independent replication of a type 2-diabetes locus on chromosome 1q21-q24. Am. J. Hum. Genet. 67, 1470-1480 (2000).
10. Wiltshire, S. et al. A genomewide scan for loci predisposing to type 2 diabetes in a U.K. population (the Diabetes UK Warren 2 Repository): analysis of 573 pedigrees provides independent replication of a susceptibility locus on chromosome 1q. Am. J. Hum. Genet. 69, 553-569 (2001).
11. Hsueh, W.C. et al. Genome-wide and fine-mapping linkage studies of type 2 diabetes and glucose traits in the Old Order Amish: evidence for a new diabetes locus on chromosome 14q11 and confirmation of a locus on chromosome 1q21-q24. Diabetes 52, 550-507 (2003).
12. Watanabe, R.M. et al. The Finland-United States investigation of non-insulin-dependent diabetes mellitus genetics (FUSION) study. II. An autosomal genome scan for diabetes-related quantitative-trait loci. Am. J. Hum. Genet. 67, 1186-1200 (2000).
13. Bodnar, J.S. et al. Positional cloning of the combined hyperlipidemia gene Hyplip1. Nat. Genet. 30, 110-116 (2002).
14. Casado, M., Vallet, V.S., Kahn, A. & Vaulont, S. Essential role in vivo of upstream stimulatory factors for a normal dietary response of the fatty acid synthase gene in the liver. J. Biol. Chem. 274, 2009-2013 (1999).
15. Vallet, V.S. et al. Differential roles of upstream stimulatory factors 1 and 2 in the transcriptional response of liver genes to glucose. J. Biol. Chem. 7, 20175-20179 (1998).
16. Ribeiro, A., Pastier, D., Kardassis, D., Chambaz, J. & Cardot, P. Cooperative binding of upstream stimulatory factor and hepatic nuclear factor 4 drives the transcription of the human apolipoprotein A-II gene. J. Biol. Chem., 274, 1216-1225 (1999).
17. Iynedjian, P.B. Identification of upstream stimulatory factor as transcriptional activator of the liver promoter of the glucokinase gene. Biochem. J. 333, 705-712 (1998).
18. Sinsheimer, J.S., Blangero, J. & Lange, K. Gamete competition models. Am. J. Hum. Genet. 66, 1168-1172 (2000).
19. Laird, N., Horvath, S. & Xu, X. Implementing a unified approach to family based tests of association. Genet. Epidemiol. 19, 36-42 (2000).
20. Martin, E.R., Bass, M.P., Gilbert, J.R., Pericak-Vance, M.A., & Hauser ER. Genotype-based association test for general pedigrees: the genotype-PDT. Genet. Epidemiol. 25, 203-213 (2003).
21. Terwilliger, J.D. & Ott, J. A haplotype-based 'haplotype relative risk' approach to detecting allelic associations. Hum. Hered. 42, 337-346 (1992).
22. Soro, A., Jauhiainen, M., Ehnholm, C. & Taskinen, M.R. Determinants of low HDL levels in familial combined hyperlipidemia. J. Lipid Res. 44, 1536-1544 (2003).
23. Peltonen, L., Pekkarinen, P. & Aaltonen, J. Messages from an isolate: lessons from the Finnish gene pool. Biol. Chem. 376, 697-704 (1995).
24. Ostermann, G., Weber, K.S., Zernecke, A., Schroder, A. & Weber, C. JAM-1 is a ligand of the beta(2) integrin LFA-1 involved in transendothelial migration of leukocytes. Nat. Immunol. 3, 151-158 (2002).
25. Vakkilainen, J. et al. LDL particle size in familial combined hyperlipidemia: effects of serum lipids, lipoprotein-modifying enzymes, and lipid transfer proteins. J. Lipid Res. 43, 598-603 (2002).
26. The Gene Ontology Consortium. Gene Ontology: tool for the unification of biology. Nat. Genet. 25, 25-29 (2000).
27. Hosack, D.A., Dennis, G. Jr., Sherman, B.T., Lane, H.C. & Lempicki, R.A. Identifying biological themes within lists of genes with EASE. Genome Biol. 4, R70.1-R70.8 (2003).
28. Lathrop, G.M., Lalouel, J.-M., Julier, C.A. & Ott, J. Strategies for multilocus linkage analysis in humans. Proc. Natl. Acad. Sci. USA 81, 3443-3446 (1984).
29. Göring, H.H. & Terwilliger, J.D. Gene mapping in the 20th and 21st centuries: statistical methods, data analysis, and experimental design. Hum. Biol. 72, 63-132 (2000).
30. Göring, H.H. & Terwilliger, J.D. Linkage analysis in the presence of errors III: marker loci and their map as nuisance parameters. Am. J. Hum. Genet. 66, 1298-1309 (2000).